AmicarbalideCAS# 3459-96-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 3459-96-9 | SDF | Download SDF |
| PubChem ID | 72074 | Appearance | Powder |
| Formula | C15H16N6O | M.Wt | 296.3 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1,3-bis(3-carbamimidoylphenyl)urea | ||
| SMILES | C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(=N)N)C(=N)N | ||
| Standard InChIKey | KRUVSRGJKCHYMY-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C15H16N6O/c16-13(17)9-3-1-5-11(7-9)20-15(22)21-12-6-2-4-10(8-12)14(18)19/h1-8H,(H3,16,17)(H3,18,19)(H2,20,21,22) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Amicarbalide Dilution Calculator
Amicarbalide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.375 mL | 16.8748 mL | 33.7496 mL | 67.4992 mL | 84.3739 mL |
| 5 mM | 0.675 mL | 3.375 mL | 6.7499 mL | 13.4998 mL | 16.8748 mL |
| 10 mM | 0.3375 mL | 1.6875 mL | 3.375 mL | 6.7499 mL | 8.4374 mL |
| 50 mM | 0.0675 mL | 0.3375 mL | 0.675 mL | 1.35 mL | 1.6875 mL |
| 100 mM | 0.0337 mL | 0.1687 mL | 0.3375 mL | 0.675 mL | 0.8437 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- SUN-B 8155
Catalog No.:BCC7405
CAS No.:345893-91-6
- SB 611812
Catalog No.:BCC6257
CAS No.:345892-71-9
- Boc-Asp-OtBu
Catalog No.:BCC3073
CAS No.:34582-32-6
- Ketotifen Fumarate
Catalog No.:BCC4531
CAS No.:34580-14-8
- D-(+)-Mannose
Catalog No.:BCC8311
CAS No.:3458-28-4
- SF1670
Catalog No.:BCC5482
CAS No.:345630-40-2
- SNS-032 (BMS-387032)
Catalog No.:BCC1152
CAS No.:345627-80-7
- Loperamide HCl
Catalog No.:BCC4380
CAS No.:34552-83-5
- Madecassoside
Catalog No.:BCN1012
CAS No.:34540-22-2
- 6,7-Dehydroferruginol
Catalog No.:BCN3218
CAS No.:34539-84-9
- Beta,beta-Dimethylacrylalkannin
Catalog No.:BCN2767
CAS No.:34539-65-6
- Arnicolide D
Catalog No.:BCN7975
CAS No.:34532-68-8
- MM 11253
Catalog No.:BCC7782
CAS No.:345952-44-5
- Wilfornine A
Catalog No.:BCN3099
CAS No.:345954-00-9
- AS601245
Catalog No.:BCC6464
CAS No.:345987-15-7
- 5-hydroxypyrazine-2-carboxylic acid
Catalog No.:BCC1311
CAS No.:34604-60-9
- Maltotetraose
Catalog No.:BCN6709
CAS No.:34612-38-9
- Maltopentaose
Catalog No.:BCN8421
CAS No.:34620-76-3
- Maltohexaose
Catalog No.:BCN6710
CAS No.:34620-77-4
- 2-Benzoyloxy-3-hydroxynortropane
Catalog No.:BCN1872
CAS No.:34622-25-8
- 1-Methoxycarbonyl-beta-carboline
Catalog No.:BCN5282
CAS No.:3464-66-2
- Amoxicillin Sodium
Catalog No.:BCC4947
CAS No.:34642-77-8
- Cyperotundone
Catalog No.:BCN8339
CAS No.:3466-15-7
- Dehydrodeguelin
Catalog No.:BCN4778
CAS No.:3466-23-7
Routine screening for potential babesicides using cultures of Babesia bovis.[Pubmed:2242963]
Int J Parasitol. 1990 Oct;20(6):797-802.
A procedure for screening of potential anti-malarial agents, based on the incorporation of [3H]hypoxanthine by the parasite, was adapted for the testing of anti-metabolites against Babesia bovis (Lismore and Samford isolates) cultured in vitro. A close correlation was found between [3H]hypoxanthine incorporation in a standard assay and percentage of parasitized cells as determined by microscopic examination. The concentrations of compounds causing 50% inhibition of [3H]hypoxanthine incorporation (ID50 values) for the established babesicides, Imidocarb and Amicarbalide, were determined to be 3 ng ml-1 (8.6 nM) and 5-10 ng ml-1 (17-34 nM), respectively. A variety of other anti-metabolites were tested in the system. ID50 values for some of the more effective compounds were tubercidin (75 nM), tetracycline (25 microM), menoctone (100 nM) and TN 108, a di-Mannich base derived from 4-(7'-trifluoromethyl-quinolin-4'-ylamino)phenol (0.13 microM). No significant differences between results with the two isolates of B. bovis were observed.
Putrescine uptake inhibition by aromatic diamidines in Leishmania infantum promastigotes.[Pubmed:8204103]
Biochem Pharmacol. 1994 May 18;47(10):1859-66.
The effect of a series of aromatic diamidines has been tested on Leishmania infantum promastigotes in both culture growth and putrescine uptake. The EC50 values calculated by means of dose-response curves were 45, 80, 165, 259 and 600 microM for 4', 6-diamidino-2-phenylindole (DAPI), dibromo propamidine, pentamidine 2-hydroxy stilbamidine and stilbamidine, respectively, although no inhibitory effects on cell growth were found at 1 mM propamidine, phenamidine and Amicarbalide. When these compounds were kinetically analysed for putrescine uptake using Lineweaver-Burk plots, the Ki values reached were: DAPI, 15 microM; pentamidine, 3 microM; dibromo propamidine, 7 microM; 2-hydroxy stilbamidine, 21 microM; stilbamidine, 20 microM; propamidine, 25 microM; and phenamidine, 95 microM. Amicarbalide, however, was not able to reduce putrescine uptake to a significant extent, even at the highest concentration studied of 1 mM.
